Exploring the Usefulness of the Dispositional Flow Scale for Outdoor Recreation Activities

The Dispositional Flow Scale (DFS), developed by Jackson et al. (1998), measures an individual’s dispositional tendency to experience flow, a psychological state of optimal experience originally conceptualized by Csikszentmihalyi in 1975. The DFS, developed in the realm of sports psychology, has primarily been used with participants of urban sports settings, such as: football, running, or tennis. This study explores the validity and reliability of applying the DFS to outdoor recreation activities. A stratified sample of 406 visitors to the Bob Marshall Wilderness Complex in Montana was contacted during the summer of 2004. A survey response rate of 74 percent was achieved with on-site contact, mail back questionnaires, follow-up reminder postcards, and replacement mailing. The primary activities reported were hiking, horseback riding, and fishing. Results from confirmatory factor analysis, a special application of structural equation modeling, confirm that the DFS displays a satisfactory level of validity and reliability when applied to these activities

“Changing Relationships with Wilderness: A New Focus for Research and Stewardship

Wilderness managers strive to provide quality recreation experiences. Because of this commitment, a need exists to further incorporate experiential aspects into current planning and management frameworks. This article suggests a focus on relationships with wilderness, moving beyond the examination of single transactions with a setting toward a consideration of the dynamic engagements visitors accumulate with wilderness over time. Understanding these relationships relative to social and cultural change may allow managers to incorporate diverse meanings into management planning and provide better protection of wilderness characte

Wildland Fire Effects on Visits and Visitors to the Bob Marshal Wilderness Complex

Wildland fire can affect wilderness visits and scientific efforts to understand visitor relationships with wilderness places. Large-scale and long-lasting fires occurred in the Bob Marshall Wilderness Complex, Montana, in 2003. A study of visitors that year to monitor long-term trends in visit and visitor characteristics was repeated in 2004 to fully understand how the 2003 fires affected trend analysis. This article considers the question of how wildland fire changes the relationship people have with wilderness, particularly related to their visits and visitor attitudes toward fire management

Threats and Changes Affecting Human Relationships with Wilderness: Implications for Management

For wilderness managers, the ability to recognize threats and changing conditions is vital. While these threats are typically associated with resource and social conditions, they can also be investigated relative to wilderness relationships. This paper explores how threats and changes may be affecting human relationships with wilderness and the possible implications for management. Previously, threats have been conceptualized as affecting ecosystem integrity or stakeholder values. This paper suggests these conceptualizations should be expanded to also consider the meanings and relationships attributed to wilderness. From such a lens, threats such as global climate change, wildland fire, and invasive species can dramatically influence both the wilderness landscape and the meanings associated with its character. They fundamentally alter the place in ways that conflict with personal histories and previous experiences. Thus, managers must be charged with finding ways to protect and foster these human relationships. Addressing threats to these relationships may also require managers to develop approaches that mitigate or adapt to these relationships over time. These approaches need to proactively define and protect a diversity of meanings and values to ensure ongoing human relationships with wilderness

Walking the walk: a phenomenological study of long distance walking

Evidence suggests that regular walking can elicit significant psychological benefits although little evidence exists concerning long distance walking. The purpose of this study was to provide detailed accounts of the experiences of long distance walkers. Phenomenological interviews were conducted with six long distance walkers. Data were transcribed verbatim before researchers independently analyzed the transcripts. Participants reported a cumulative effect with positive feelings increasing throughout the duration of the walk. Long distance walking elicited positive emotions, reduced the effects of life-stress, and promoted an increased sense of well-being and personal growth. Results are aligned to theories and concepts from positive psychology

Ambroxol as a novel disease-modifying treatment for Parkinson\u27s disease dementia: Protocol for a single-centre, randomized, double-blind, placebo-controlled trial

© 2019 The Author(s). Background: Currently there are no disease-modifying treatments for Parkinson\u27s disease dementia (PDD), a condition linked to aggregation of the protein α-synuclein in subcortical and cortical brain areas. One of the leading genetic risk factors for Parkinson\u27s disease is being a carrier in the gene for β-Glucocerebrosidase (GCase; gene name GBA1). Studies in cell culture and animal models have shown that raising the levels of GCase can decrease levels of α-synuclein. Ambroxol is a pharmacological chaperone for GCase and is able to raise the levels of GCase and could therefore be a disease-modifying treatment for PDD. The aims of this trial are to determine if Ambroxol is safe and well-tolerated by individuals with PDD and if Ambroxol affects cognitive, biochemical, and neuroimaging measures. Methods: This is a phase II, single-centre, double-blind, randomized placebo-controlled trial involving 75 individuals with mild to moderate PDD. Participants will be randomized into Ambroxol high-dose (1050 mg/day), low-dose (525 mg/day), or placebo treatment arms. Assessments will be undertaken at baseline, 6-months, and 12-months follow up times. Primary outcome measures will be the Alzheimer\u27s disease Assessment Scale-cognitive subscale (ADAS-Cog) and the ADCS Clinician\u27s Global Impression of Change (CGIC). Secondary measures will include the Parkinson\u27s disease Cognitive Rating Scale, Clinical Dementia Rating, Trail Making Test, Stroop Test, Unified Parkinson\u27s disease Rating Scale, Purdue Pegboard, Timed Up and Go, and gait kinematics. Markers of neurodegeneration will include MRI and CSF measures. Pharmacokinetics and pharmacodynamics of Ambroxol will be examined through plasma levels during dose titration phase and evaluation of GCase activity in lymphocytes. Discussion: If found effective and safe, Ambroxol will be one of the first disease-modifying treatments for PDD. Trial registration: ClinicalTrials.gov NCT02914366, 26 Sep 2016/retrospectively registered

Alpha2-Containing Glycine Receptors Promote Neonatal Spontaneous Activity of Striatal Medium Spiny Neurons and Support Maturation of Glutamatergic Inputs

Glycine receptors (GlyRs) containing the alpha 2 subunit are highly expressed in the developing brain, where they regulate neuronal migration and maturation, promote spontaneous network activity and subsequent development of synaptic connections. Mutations in GLRA2 are associated with autism spectrum disorder, but the underlying pathophysiology is not described yet. Here, using Glra2-knockout mice, we found a GIyR-dependent effect on neonatal spontaneous activity of dorsal striatum medium spiny neurons (MSNs) and maturation of the incoming glutamatergic innervation. Our data demonstrate that functional GlyRs are highly expressed in MSNs of one-week-old mice, but they do not generate endogenous chloride-mediated tonic or phasic current. Despite of that, knocking out the Glra2 severely affects the shape of action potentials and impairs spontaneous activity and the frequency of miniature AMPA receptor-mediated currents in MSNs. This reduction in spontaneous activity and glutamatergic signaling can attribute to the observed changes in neonatal behavioral phenotypes as seen in ultrasonic vocalizations and righting reflex. In adult G/ra2-knockout animals, the glutamatergic synapses in MSNs remain functionally underdeveloped. The number of glutamatergic synapses and release probability at presynaptic site remain unaffected, but the amount of postsynaptic AMPA receptors is decreased. This deficit is a consequence of impaired development of the neuronal circuitry since acute inhibition of GlyRs by strychnine in adult MSNs does not affect the properties of glutamatergic synapses. Altogether, these results demonstrate that GIyR-mediated signaling supports neonatal spontaneous MSN activity and, in consequence, promotes the functional maturation of glutamatergic synapses on MSNs. The described mechanism might shed light on the pathophysiological mechanisms in GLRA2-linked autism spectrum disorder cases

How Can Consumer Research Contribute to Increased Understanding of Tourist Experiences? A Conceptual Review

Author's accepted version (postprint).This is an Accepted Manuscript of an article published by Taylor & Francis in Scandinavian Journal of Hospitality and Tourism on 24/07/2015, available online: http://wwww.tandfonline.com/10.1080/15022250.2015.1065591

Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative

Objectives: Caregiving burdens are a substantial concern in the clinical care of persons with neurodegenerative disorders. In the Ontario Neurodegenerative Disease Research Initiative, we used the Zarit\u27s Burden Interview (ZBI) to examine: (1) the types of burdens captured by the ZBI in a cross-disorder sample of neurodegenerative conditions (2) whether there are categorical or disorder-specific effects on caregiving burdens, and (3) which demographic, clinical, and cognitive measures are related to burden(s) in neurodegenerative disorders?. Methods/Design: N = 504 participants and their study partners (e.g., family, friends) across: Alzheimer\u27s disease/mild cognitive impairment (AD/MCI; n = 120), Parkinson\u27s disease (PD; n = 136), amyotrophic lateral sclerosis (ALS; n = 38), frontotemporal dementia (FTD; n = 53), and cerebrovascular disease (CVD; n = 157). Study partners provided information about themselves, and information about the clinical participants (e.g., activities of daily living (ADL)). We used Correspondence Analysis to identify types of caregiving concerns in the ZBI. We then identified relationships between those concerns and demographic and clinical measures, and a cognitive battery. Results: We found three components in the ZBI. The first was “overall burden” and was (1) strongly related to increased neuropsychiatric symptoms (NPI severity r = 0.586, NPI distress r = 0.587) and decreased independence in ADL (instrumental ADLs r = −0.566, basic ADLs r = −0.43), (2) moderately related to cognition (MoCA r = −0.268), and (3) showed little-to-no differences between disorders. The second and third components together showed four types of caregiving concerns: current care of the person with the neurodegenerative disease, future care of the person with the neurodegenerative disease, personal concerns of study partners, and social concerns of study partners. Conclusions: Our results suggest that the experience of caregiving in neurodegenerative and cerebrovascular diseases is individualized and is not defined by diagnostic categories. Our findings highlight the importance of targeting ADL and neuropsychiatric symptoms with caregiver-personalized solutions